Your browser doesn't support javascript.
loading
Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.
Tubeuf, Hélène; Caputo, Sandrine M; Sullivan, Teresa; Rondeaux, Julie; Krieger, Sophie; Caux-Moncoutier, Virginie; Hauchard, Julie; Castelain, Gaia; Fiévet, Alice; Meulemans, Laëtitia; Révillion, Françoise; Léoné, Mélanie; Boutry-Kryza, Nadia; Delnatte, Capucine; Guillaud-Bataille, Marine; Cleveland, Linda; Reid, Susan; Southon, Eileen; Soukarieh, Omar; Drouet, Aurélie; Di Giacomo, Daniela; Vezain, Myriam; Bonnet-Dorion, Françoise; Bourdon, Violaine; Larbre, Hélène; Muller, Danièle; Pujol, Pascal; Vaz, Fátima; Audebert-Bellanger, Séverine; Colas, Chrystelle; Venat-Bouvet, Laurence; Solano, Angela R; Stoppa-Lyonnet, Dominique; Houdayer, Claude; Frebourg, Thierry; Gaildrat, Pascaline; Sharan, Shyam K; Martins, Alexandra.
Afiliación
  • Tubeuf H; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Caputo SM; Interactive Biosoftware, Rouen, France.
  • Sullivan T; Department of Genetics, Institut Curie, Paris, France.
  • Rondeaux J; PSL Research University, Paris, France.
  • Krieger S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Caux-Moncoutier V; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Hauchard J; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Castelain G; Laboratory of Cancer Biology and Genetics, Centre François Baclesse, Caen, France - Normandie University, UNICAEN, Caen, France.
  • Fiévet A; Department of Genetics, Institut Curie, Paris, France.
  • Meulemans L; PSL Research University, Paris, France.
  • Révillion F; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Léoné M; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Boutry-Kryza N; Department of Genetics, Institut Curie, Paris, France.
  • Delnatte C; INSERM U830, University Paris Descartes, Paris, France.
  • Guillaud-Bataille M; Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France.
  • Cleveland L; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Reid S; Unit of Human Molecular Oncology, Centre Oscar Lambret, Lille, France.
  • Southon E; Hospices Civils de Lyon, Bron, France.
  • Soukarieh O; Hospices Civils de Lyon, Bron, France.
  • Drouet A; Department of Genetics, Nantes University Hospital, Nantes, France.
  • Di Giacomo D; Service Génétique des Tumeurs, Gustave Roussy, Villejuif, France.
  • Vezain M; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Bonnet-Dorion F; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Bourdon V; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • Larbre H; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Muller D; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Pujol P; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Vaz F; Inserm U1245, UNIROUEN, Normandie University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Audebert-Bellanger S; Inserm U1218, Department of Genetics, Institut Bergonié, Bordeaux, France.
  • Colas C; Department of Genetics, Institut Paoli-Calmettes, Marseille, France.
  • Venat-Bouvet L; Laboratoire d'Oncogénétique Moléculaire, Institut Godinot, Reims, France.
  • Solano AR; Unité d'Oncogénétique, Centre Paul Strauss, Strasbourg, France.
  • Stoppa-Lyonnet D; Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
  • Houdayer C; Breast Cancer Risk Evaluation Clinic, Portuguese Institute of Oncology of Lisbon, Lisbon, Portugal.
  • Frebourg T; Département de Génétique et Biologie de la Reproduction, CHU Morvan, Brest, France.
  • Gaildrat P; Department of Genetics, Institut Curie, Paris, France.
  • Sharan SK; PSL Research University, Paris, France.
  • Martins A; Service Oncologie, CHU Dupuytren, Limoges, France.
Cancer Res ; 80(17): 3593-3605, 2020 09 01.
Article en En | MEDLINE | ID: mdl-32641407
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Predisposición Genética a la Enfermedad / Genes BRCA2 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Predisposición Genética a la Enfermedad / Genes BRCA2 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Francia